Department of Clinical Pharmacy and Biopharmacy, University of Uyo, Uyo, Akwa Ibom State, Nigeria.
Department of Clinical Pharmacy and Pharmacy Management, University of Nigeria, Nsukka, Enugu State, Nigeria.
Value Health Reg Issues. 2023 May;35:95-101. doi: 10.1016/j.vhri.2023.01.008. Epub 2023 Mar 16.
This study aimed to assess willingness to pay (WTP) for clinical pharmacy services among people with diabetes and to determine the factors affecting WTP for these services.
This was a cross-sectional exit survey of 450 people with diabetes visiting 15 community pharmacies in Uyo metropolis, Akwa Ibom State, Nigeria, between August and September 2021. Self-reported questionnaires were administered to eligible patients just before leaving the community pharmacy. Data were analyzed using SPSS (version 25.0). Statistical significance was set at P < .05.
Response rate was 87.3%. Two hundred respondents (50.9%) were willing to pay an average amount of US$2.83 (minimum-maximum, US$0.12-US$24.27) for clinical pharmacy services. The two most often cited reasons for those who were unwilling to pay were their inability to pay and their opposition to paying for any healthcare services. Employment status (P < .001), personal monthly income (P < .001), satisfaction with income (P < .001), household monthly income (P < .001), health insurance coverage (P < .001), insulin use (P < .001), perception of the pharmacist's relevance in healthcare (P = .013) and in diabetes care (P < .001), and satisfaction with the pharmacist's services (P < .001) significantly affected WTP choices. None of the patient characteristics predicted the maximum amounts patients were willing to pay.
Many of the people with diabetes assessed were willing to pay for clinical services at a reasonable price. Although most patient variables affected their WTP choices, none of the variables predicted the maximum amount they were willing to pay. For possible remuneration for clinical services, community pharmacists should continue to grow their practices and stay current with patient care.
本研究旨在评估糖尿病患者对临床药学服务的支付意愿（WTP），并确定影响这些服务 WTP 的因素。
这是一项横断面的 450 名糖尿病患者的出口调查，这些患者在 2021 年 8 月至 9 月期间访问了尼日利亚阿克瓦伊博姆州乌约大都市区的 15 家社区药店。在离开社区药店之前，向符合条件的患者发放了自我报告的调查问卷。使用 SPSS（版本 25.0）分析数据。统计显著性设为 P <.05。
应答率为 87.3%。200 名受访者（50.9%）愿意平均支付 2.83 美元（最低-最高，0.12-24.27 美元）用于临床药学服务。那些不愿意支付的人最常提到的两个原因是他们无法支付和反对支付任何医疗保健服务。就业状况（P <.001）、个人月收入（P <.001）、收入满意度（P <.001）、家庭月收入（P <.001）、健康保险覆盖范围（P <.001）、胰岛素使用（P <.001）、对药剂师在医疗保健中的相关性的看法（P =.013）和在糖尿病护理中的相关性（P <.001）以及对药剂师服务的满意度（P <.001）显著影响 WTP 选择。患者特征均不能预测患者愿意支付的最高金额。
评估的许多糖尿病患者愿意以合理的价格支付临床服务费用。尽管大多数患者变量影响了他们的 WTP 选择，但没有一个变量预测了他们愿意支付的最高金额。对于可能的临床服务报酬，社区药剂师应继续扩大业务范围，保持患者护理的最新水平。
